Allergan

Allergan is developing a treatment for the redness of rosacea based on Oxymetazoline, currently called AGN-199201. Allergan is also known to rosacea sufferers because they make Restasis and Aczone.

Recent Rosacea Blog Posts

Rhofade good for at least a year and gentler than Mirvaso

If you decide to try Allergan’s topical for redness – Rhofade, is it likely to work for you, and how long should you expect it to continue to work for you? Well, a year long study of users of Rhofade has found that the vast majority continued to enjoy ongoing significant relief from their facial […]

Continue Reading

Allergan will be pleased to discover that they scored a free (one presumes) mention of their Rhofade product in the New York Times Fashion & Style section today. Given that Rhofade is a prescription item, this amounts to publicity of the sort that they cannot buy. How to Go Makeup-Free This Summer By CRYSTAL MARTIN AUG. 1, […]

Continue Reading

Rhofade patents to last until 2031

  Allergan lists the patents that it claims protects the intellectual property behind their prescription products. The following patents are claimed by Allergan to be associated with Rhofade. Rosacea News was watching the patents the were surfacing for oxymetazoline and noticed two of the claimed patents in 2012 – see Allergan Developing Oxymetazoline (AGN-199201/V-101) Cream Formulations. […]

Continue Reading

Rhofade User Reviews

Allergan’s Oxymetazoline based cream, Rhofade (oxymetazoline hydrochloride cream 1%) – for the treatment of the redness of rosacea is now generally available. Does it work to effectively and safely reduce the redness of rosacea? You have come to the right page to find out. Some Oxymetazoline History For rosacea sufferers it has been a long […]

Continue Reading

Rhofade website and prescribing information is live

The official web site for Rhofade has gone live and now contains information that Allergan has not previously made public. Official web sites for prescription products normally contain statistics summarising clinical trial data, official dosage information, and other notes for doctors wanting to understand the cost and benefit of a new treatment. For rosacea sufferers, […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.